<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31-molecules-25-05557">
 <label>31.</label>
 <element-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Şoica</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Antal</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Andrica</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Racoviceanu</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Moacă</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ardelean</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Ghiulai</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Avram</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Danciu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Coricovac</surname>
    <given-names>D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Lupan-skeleton pentacyclic triterpenes with activity against skin cancer: Preclinical trials evolution</article-title>
  <source>Unique Aspects of Anti-Cancer Drug Development</source>
  <publisher-name>IntechOpen</publisher-name>
  <publisher-loc>Rijeka, Croatia</publisher-loc>
  <year>2017</year>
  <fpage>87</fpage>
  <lpage>114</lpage>
 </element-citation>
</ref>
